Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (1021-1030 of 1,104) with videos related to

Pageof 111
Sort By:
Journal of Korean Medical Science|October 24, 2023
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From KoreaJin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, et al.
Journal of Translational Medicine|October 18, 2023
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinomaYoungil Koh, Hyemin Kim, So Young Joo, et al.
Radiation Oncology Journal|October 21, 2015
Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South KoreaSoo Yoon Sung, Min Kyu Kang, Chul Seung Kay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2021
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation StudyLihua E Budde, Sarit Assouline, Laurie H Sehn, et al.
Acta Haematologica|December 5, 2012
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantationDong-Yeop Shin, Inho Kim, Jin Hee Kim, et al.
Annals of Hematology|June 23, 2009
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidineDae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, et al.
European Journal of Haematology|March 17, 2009
Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromesChan H Park, Bruce F Kimler, Seong Yoon Yi, et al.
British Journal of Haematology|June 28, 2017
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trialJesús F San-Miguel, Vania T M Hungria, Sung-Soo Yoon, et al.
Haematologica|July 29, 2010
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studySeok Jin Kim, Jong Wook Lee, Chul Won Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)Sung-Hoon Jung, Je-Jung Lee, Jin Seok Kim, et al.
Pageof 111

Showing results (1021-1030 of 1,104) with videos related to

Sort By:
Pageof 111
Journal of Korean Medical Science|October 24, 2023
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From KoreaJin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, et al.
Journal of Translational Medicine|October 18, 2023
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinomaYoungil Koh, Hyemin Kim, So Young Joo, et al.
Radiation Oncology Journal|October 21, 2015
Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South KoreaSoo Yoon Sung, Min Kyu Kang, Chul Seung Kay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2021
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation StudyLihua E Budde, Sarit Assouline, Laurie H Sehn, et al.
Acta Haematologica|December 5, 2012
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantationDong-Yeop Shin, Inho Kim, Jin Hee Kim, et al.
Annals of Hematology|June 23, 2009
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidineDae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, et al.
European Journal of Haematology|March 17, 2009
Depletion of L-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromesChan H Park, Bruce F Kimler, Seong Yoon Yi, et al.
British Journal of Haematology|June 28, 2017
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trialJesús F San-Miguel, Vania T M Hungria, Sung-Soo Yoon, et al.
Haematologica|July 29, 2010
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studySeok Jin Kim, Jong Wook Lee, Chul Won Jung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)Sung-Hoon Jung, Je-Jung Lee, Jin Seok Kim, et al.
Pageof 111